Health ❯ Healthcare ❯ Patient Care ❯ Treatment Options

Oral Medications

FDA Approves Lipfendra, First Oral PCSK9 Pill to Lower LDL Cholesterol

The once‑daily tablet offers an alternative to injectable PCSK9 drugs, with price, insurer coverage and ongoing outcomes data set to determine how widely it is used.

31 ARTICLES

4w ago

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

16 ARTICLES

2mo ago

MHRA Approves Wegovy Daily Pill for Weight Loss in UK

45 ARTICLES

2mo ago

Pfizer’s Once‑Monthly GLP‑1 Shows Strong Weight Loss but Raises Dosing‑Safety Questions

3 ARTICLES

2mo ago

Mezigdomide Triplet Cuts Risk of Myeloma Progression by 52% in Phase 3 Trial

27 ARTICLES

3mo ago

New Trials Show Daily Pills Can Help Maintain Weight Loss After GLP-1 Injections

10 ARTICLES

4mo ago

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

3 ARTICLES

5mo ago

FDA Approves First All-Oral, Fixed-Duration First-Line CLL/SLL Regimen: Calquence Plus Venetoclax

14 ARTICLES

7mo ago

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

38 ARTICLES

7mo ago

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

8 ARTICLES

8mo ago

FDA Clears First New Oral Gonorrhea Antibiotics in Over 30 Years

3 ARTICLES

10mo ago

FDA Clears Novartis' Rhapsido, First Oral BTK Inhibitor for Chronic Hives

44 ARTICLES

11mo ago

Oral GLP-1 Pill Orforglipron Delivers Phase III Weight Loss as Obesity Care Broadens Beyond Injections

32 ARTICLES

11mo ago

Lilly’s Orforglipron Pill Hits Phase 3 Goals, Clearing Path to Global Filings

9 ARTICLES

last yr.

FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis

7 ARTICLES

last yr.

FDA Grants Accelerated Approval to Zongertinib for HER2-Mutant Lung Cancer

12 ARTICLES

last yr.

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

Oral Medications

FDA Approves Lipfendra, First Oral PCSK9 Pill to Lower LDL Cholesterol

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

MHRA Approves Wegovy Daily Pill for Weight Loss in UK

Pfizer’s Once‑Monthly GLP‑1 Shows Strong Weight Loss but Raises Dosing‑Safety Questions

Mezigdomide Triplet Cuts Risk of Myeloma Progression by 52% in Phase 3 Trial

New Trials Show Daily Pills Can Help Maintain Weight Loss After GLP-1 Injections

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

FDA Approves First All-Oral, Fixed-Duration First-Line CLL/SLL Regimen: Calquence Plus Venetoclax

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

Never miss stories about

Oral Medications

FDA Clears First New Oral Gonorrhea Antibiotics in Over 30 Years

FDA Clears Novartis' Rhapsido, First Oral BTK Inhibitor for Chronic Hives

Oral GLP-1 Pill Orforglipron Delivers Phase III Weight Loss as Obesity Care Broadens Beyond Injections

Lilly’s Orforglipron Pill Hits Phase 3 Goals, Clearing Path to Global Filings

FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis

FDA Grants Accelerated Approval to Zongertinib for HER2-Mutant Lung Cancer

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

Never miss stories about

Oral Medications